Glecaprevir is being developed as a treatment of chronic hepatitis C infection in co-formulation with an HCV NS5A inhibitor pibrentasvir. Reference standards of Glecaprevir API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Glecaprevir
Catalogue No.:PA 07 0850000
CAS :
Molecular Formula : C38H46F4N6O9S
Molecular Weight : 838.87
(1R,2R)-1-Amino-2-(difluoromethyl)-N-[(1-methylcyclopropyl)sulfonyl]cyclopropanecarboxamide Hydrochloride
Catalogue No.:PA 07 0851000
Molecular Formula : C9H15ClF2N2O3S
Molecular Weight : 304.74
1-Hydroxy-2(1H)-pyridinone
Catalogue No.:PA 07 0851001
Molecular Formula : C5H5NO2
Molecular Weight : 111.1
Glecaprevir-13C,D3
Catalogue No.:PA STI 089297
Molecular Formula : C38H43D3F4N6O9S
Molecular Weight : 841.89
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
